| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.64B | 1.54B | 1.55B | 1.56B | 1.53B |
| Gross Profit | 603.80M | 566.60M | 565.00M | 570.50M | 568.50M |
| EBITDA | 175.30M | 158.90M | 172.30M | 173.70M | 199.90M |
| Net Income | 38.50M | 18.40M | 29.80M | 31.90M | 58.80M |
Balance Sheet | |||||
| Total Assets | 1.10B | 1.08B | 1.07B | 1.10B | 1.16B |
| Cash, Cash Equivalents and Short-Term Investments | 91.70M | 86.30M | 97.50M | 99.50M | 123.40M |
| Total Debt | 719.80M | 705.30M | 675.80M | 691.30M | 742.10M |
| Total Liabilities | 969.80M | 932.50M | 909.80M | 940.10M | 996.10M |
| Stockholders Equity | 130.50M | 145.30M | 163.30M | 164.40M | 160.80M |
Cash Flow | |||||
| Free Cash Flow | 177.30M | 135.90M | 147.20M | 85.30M | 74.90M |
| Operating Cash Flow | 200.10M | 162.00M | 179.30M | 125.70M | 101.40M |
| Investing Cash Flow | -25.20M | -14.70M | -30.90M | -38.10M | 98.30M |
| Financing Cash Flow | -169.50M | -158.50M | -150.40M | -111.50M | -82.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | £4.25B | 16.92 | 23.58% | 2.57% | 0.13% | -0.06% | |
70 Outperform | £211.44M | 6.79 | 22.57% | 2.49% | 4.84% | 103.78% | |
68 Neutral | £67.91M | 3.60 | 99.37% | 6.86% | 17.48% | ― | |
66 Neutral | £4.76B | 24.08 | 3.91% | 3.99% | -0.13% | -43.71% | |
65 Neutral | £1.58B | 6.72 | 121.78% | 3.99% | 3.78% | 3.29% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | £464.85M | 13.99 | 29.52% | 3.83% | 3.98% | -22.94% |